Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion type Assertion NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_head.
- NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion description "[Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_provenance.
- NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion evidence source_evidence_literature NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_provenance.
- NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion SIO_000772 25175730 NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_provenance.
- NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion wasDerivedFrom befree-2016 NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_provenance.
- NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_assertion wasGeneratedBy ECO_0000203 NP1215703.RAPxliIq8mJYRnaFYquvg8TrbM5rkQE7_DGgwLt2qf1gQ130_provenance.